Karyopharm Therapeutics
KPTI
#8602
Rank
A$0.15 B
Marketcap
$1.24
Share price
14.66%
Change (1 day)
-34.41%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -$1.98

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.98. In 2022 the company made an earnings per share (EPS) of -$3.04 a decrease over its 2021 EPS that were of -$2.49.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.98-34.91%
2022-$3.0422.29%
2021-$2.49-39.19%
2020-$4.09-15.48%
2019-$4.843.19%
2018-$4.6911.79%
2017-$4.20-4.44%
2016-$4.39-11.75%
2015-$4.9837.76%
2014-$3.61-74.5%
2013-$14.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.73-238.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.95-400.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.46-325.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.42-121.46%๐Ÿ‡บ๐Ÿ‡ธ USA